Medium and long-term cognitive function in heart transplant recipients is the main theme of Britta Susanne Bürker‘s PhD thesis.
MAIN RESULTS:
THESIS DEFENCE:
Thesis: Mood and Cognitive Outcome after Heart Transplantation: The MOODHEART study.
Candidate: Britta Susanne Bürker
Time: September 10, 2019 at 13:15
Place: Oslo University Hospital, Rikshospitalet: Rødt auditorium
Link to university website
SUMMARY:
(1) Cognitive assessment should be integrated into the follow-up of patients after heart transplantation. Bürker and co-workers examined the cognitive function of 37 patients three years after transplantation, of which about half received standard immunosuppressive therapy with the calcineurine inhibitor cyclosporine. The rest had been randomly assigned to experimental immunosuppression with everolimus and a much lower dose of cyclosporin, shown to retain renal function better and reduce calcification of the large blood vessels of the new heart. There was no difference in cognitive function between the two groups. Overall, 40% of patients had cognitive impairments such as attention, memory or language problems.
(2) Nearly 40% of long-term heart transplant survivors exhibit impaired test performance on several cognitive measures. All 37 patients included had survived for more than 16 years after transplantation, and they generally scored below population norms on cognitive parameters like precessing speed, executive functions, memory and language. 30 % qualified for mild cognitive impairement.
(3) Patients with clinical significant depression five years after heart transplantation have doubled risk of premature death. 141 heart transplant recipients were included in the study and followed for up to 20 years after transplantation.
REFERENCES:
(1) Bürker, B. S., Gullestad, L., Gude, E., Relbo Authen, A., Grov, I., Hol, P. K., Andreassen, A. K., Arora, S., Dew, M. A., Fiane, A. E., Haraldsen, I. R., Malt, U. F., & Andersson, S. (2017). Cognitive function after heart transplantation: Comparing everolimus‐based and calcineurin inhibitor‐based regimens. Clinical transplantation, 31(4), e12927.
(2) Bürker, B. S., Gude, E., Gullestad, L., Grov, I., Relbo Authen, A., Andreassen, A. K., Havik, O. E., Dew, M. A., Fiane, A., Haraldsen, I. R., Malt, U. F., & Andersson, S. (2017). Cognitive function among long‐term survivors of heart transplantation. Clinical transplantation, 31(12), e13143.
(3) Bürker, B. S., Gullestad, L., Gude, E., Havik, O. E., Authen, A. R., Grov, I., Andreassen, A. K., Fiane, A. E., Haraldsen, I. R., Dew, M. A., & Andersson, S. (2019). The predictive value of depression in the years after heart transplantation for mortality during long-term follow-up. Psychosomatic medicine, 81(6), 513-520.
- priority at NORHEART events
- visibility to other cardiovascular researchers
- e-mail updates and Newsletter
- membership free of charge
Join the Friends of NORHEART mailing list if you want to receive our newsletter without membership.
NORHEART is excited to launch our brand new LinkedIn page. On this page you will…
More than 100 participants attended the 22nd Annual Norwegian Symposium on Heart Research, hosted by…
Approximately 25 researchers met in Trondheim for the new workshop called “Advancing Ischemic Heart Disease…
Cardiac researchers and clinical cardiologists need to know key concepts and terms for measuring and describing…